BEIJING, Feb. 18, 2011 /PRNewswire-Asia-FirstCall/ — China
Medical Technologies, Inc. (the “Company”) (Nasdaq:
CMED), a leading China-based advanced in-vitro diagnostic
(“IVD”) company, announced its unaudited financial results for the
third fiscal quarter ended December 31, 2010 (“3Q FY2010”)
today.
3Q FY2010 HighlightsFor the Three Months
EndedDecember 31,
2009December 31,
2010December 31,
2010RMBRMBUS$% change(in thousands except for per ADS
information)Revenues, net172,320
223,948
33,932
30.0Adjusted EBITDA92,133
131,544
19,931
42.8Non-GAAP net income45,618
75,642
11,461
65.8Non-GAAP diluted earnings per ADS*1.74
2.87
0.43
64.9Nine Months FY2010 HighlightsFor the Nine
Months EndedDecember 31,
2009December 31,
2010December 31,
2010RMBRMBUS$% change(in thousands except for per ADS
information)Revenues, net547,343
611,952
92,720
11.8Adjusted EBITDA287,989
353,010
53,486
22.6Non-GAAP net income135,819
198,054
30,008
45.8Non-GAAP diluted earnings per ADS*5.15
7.55
1.14
46.6Outlook for 4Q FY2010
Target revenues are expected to be approximately RMB234.0 million
(US$35.5 million), representing a year-over-year increase of 33.2%.
Target non-GAAP net income is expected to be approximately RMB71.0
million (US$10.8 million), representing a year-over-year increase
of 37.9%. The Company has taken into account the impact of
incremental cash interest arising from the issuance of 2016
Convertible Notes in December 2010 to refinance its 2011
Convertible Notes. Target non-GAAP diluted earnings per ADS* is
expected to be approximately RMB2.69 (US$0.41), representing a
year-over-year increase of 35.9%.
‘/>”/>
